Ligand validation:2LH3

HEM: PROTOPORPHYRIN IX CONTAINING FE

HEM is a Ligand Of Interest in 2LH3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2LH3_HEM_A_155	30%	3%	0.183	0.847	3.88	2.32	29	20	2	0	100%	1
2LH7_HEM_A_154	32%	3%	0.161	0.831	3.8	2.35	30	20	7	0	100%	0.9302
1LH3_HEM_A_155	31%	2%	0.184	0.853	4.1	2.6	31	20	2	0	100%	1
1LH6_HEM_A_154	30%	2%	0.189	0.853	4.28	2.71	29	16	6	0	100%	0.9302
2LH6_HEM_A_154	30%	2%	0.19	0.853	4.08	2.53	30	20	2	0	100%	0.9302
1LH7_HEM_A_154	29%	2%	0.168	0.826	4.04	2.58	29	21	7	0	100%	0.9302
1FHF_HEM_A_350	100%	17%	0.021	0.997	1.8	1.82	12	3	4	0	100%	1
1HBH_HEM_B_148	100%	19%	0.016	0.998	1.59	1.89	8	11	2	0	100%	1
2D2C_HEM_A_301	100%	9%	0.024	0.999	2.2	2.28	9	12	4	0	100%	1
3EJD_HEM_B_405	100%	17%	0.018	0.998	1.9	1.69	6	8	2	0	100%	1
3EJE_HEM_B_405	100%	18%	0.022	0.997	1.91	1.6	8	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.